NeoGenomics: Q4 Earnings Snapshot

FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Thursday reported a loss of $22.7 million in its fourth quarter.

On a per-share basis, the Fort Myers, Florida-based company said it had a loss of 18 cents. Losses, adjusted for costs related to mergers and acquisitions and stock option expense, were 6 cents per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.

The operator of cancer-focused testing laboratories posted revenue of $138.7 million in the period, also beating Street forecasts. Six analysts surveyed by Zacks expected $130 million.

For the year, the company reported that its loss widened to $144.3 million, or $1.16 per share. Revenue was reported as $509.7 million.

NeoGenomics expects full-year results to range from a loss of 38 cents per share to a loss of 32 cents per share.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on NEO at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up